TM Transition Corp

Alnylam Pharmaceuticals is a biopharmaceutical company. The company develops novel therapeutics based on the biological breakthrough known as ribonucleic acid interference. The company applies ribonucleic acid interference to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies. This discovery enables the creation of a broad new class of human therapeutics. Alnylam Pharmaceuticals maintains partnerships with leading pharmaceutical and medical technology companies to drive further developments and capabilities. Major alliances include Merck, Medtronic and Novartis. Alnylam Pharmaceuticals, founded in 2002, maintains global headquarters in Cambridge, Mass., and has an additional operating unit in Kulmbach, Germany.

Neuroelectrics Corporation, based in Cambridge, MA, is at the forefront of revolutionizing neurocircuit therapeutics by developing cloud-based personalized neuromodulation solutions. Their innovative Starstim platform integrates advanced EEG monitoring and multichannel Transcranial Electrical Stimulation (tES) to target dysfunctional neural circuits associated with various brain disorders. The company's mission is to enhance the lives of individuals living with brain diseases by offering non-invasive, personalized brain stimulation therapies. By combining breakthroughs in computational neuroscience and data science, Neuroelectrics aims to provide a complementary approach to traditional pharmacological treatments, focusing on conditions like depression and epilepsy. Generated from the website

Philips North America LLC, located in Cambridge, MA, is a leading health technology company dedicated to improving people's lives through meaningful innovation. The company focuses on delivering advanced healthcare solutions, consumer products, and services across various sectors, including healthcare, lighting, and automotive. With a commitment to sustainability and social responsibility, Philips aims to enhance the quality of care and well-being for individuals and communities. The organization emphasizes collaboration and innovation to address the evolving needs of healthcare professionals and consumers alike. Generated from the website